BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17848567)

  • 1. Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members.
    Huang J; Liang Z; Yang B; Tian H; Ma J; Zhang H
    J Biol Chem; 2007 Nov; 282(46):33632-33640. PubMed ID: 17848567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effect of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members on the activity of cellular microRNAs.
    Zhang H
    Prog Mol Subcell Biol; 2010; 50():71-83. PubMed ID: 19841882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10.
    Liu C; Zhang X; Huang F; Yang B; Li J; Liu B; Luo H; Zhang P; Zhang H
    J Biol Chem; 2012 Aug; 287(35):29373-83. PubMed ID: 22791714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
    He Z; Zhang W; Chen G; Xu R; Yu XF
    J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules.
    Kozak SL; Marin M; Rose KM; Bystrom C; Kabat D
    J Biol Chem; 2006 Sep; 281(39):29105-19. PubMed ID: 16887808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation.
    Santa-Marta M; da Silva FA; Fonseca AM; Goncalves J
    J Biol Chem; 2005 Mar; 280(10):8765-75. PubMed ID: 15611076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules.
    Gallois-Montbrun S; Kramer B; Swanson CM; Byers H; Lynham S; Ward M; Malim MH
    J Virol; 2007 Mar; 81(5):2165-78. PubMed ID: 17166910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.
    Shirakawa K; Takaori-Kondo A; Yokoyama M; Izumi T; Matsui M; Io K; Sato T; Sato H; Uchiyama T
    Nat Struct Mol Biol; 2008 Nov; 15(11):1184-91. PubMed ID: 18836454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting APOBEC3G substrate specificity by nucleoside analog interference.
    Rausch JW; Chelico L; Goodman MF; Le Grice SF
    J Biol Chem; 2009 Mar; 284(11):7047-58. PubMed ID: 19136562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.
    Huthoff H; Autore F; Gallois-Montbrun S; Fraternali F; Malim MH
    PLoS Pathog; 2009 Mar; 5(3):e1000330. PubMed ID: 19266078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses.
    Fehrholz M; Kendl S; Prifert C; Weissbrich B; Lemon K; Rennick L; Duprex PW; Rima BK; Koning FA; Holmes RK; Malim MH; Schneider-Schaulies J
    J Gen Virol; 2012 Mar; 93(Pt 3):565-576. PubMed ID: 22170635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
    J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.
    Oliva H; Pacheco R; Martinez-Navio JM; Rodríguez-García M; Naranjo-Gómez M; Climent N; Prado C; Gil C; Plana M; García F; Miró JM; Franco R; Borras FE; Navaratnam N; Gatell JM; Gallart T
    Immunol Cell Biol; 2016 Aug; 94(7):689-700. PubMed ID: 26987686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
    Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
    J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides.
    Reingewertz TH; Britan-Rosich E; Rotem-Bamberger S; Viard M; Jacobs A; Miller A; Lee JY; Hwang J; Blumenthal R; Kotler M; Friedler A
    Bioorg Med Chem; 2013 Jun; 21(12):3523-32. PubMed ID: 23545135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells.
    Pido-Lopez J; Whittall T; Wang Y; Bergmeier LA; Babaahmady K; Singh M; Lehner T
    J Immunol; 2007 Feb; 178(3):1671-9. PubMed ID: 17237417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure.
    Kim EY; Bhattacharya T; Kunstman K; Swantek P; Koning FA; Malim MH; Wolinsky SM
    J Virol; 2010 Oct; 84(19):10402-5. PubMed ID: 20660203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activity.
    McDougall WM; Smith HC
    Biochem Biophys Res Commun; 2011 Sep; 412(4):612-7. PubMed ID: 21856286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.
    Lu X; Zhang T; Xu Z; Liu S; Zhao B; Lan W; Wang C; Ding J; Cao C
    J Biol Chem; 2015 Feb; 290(7):4010-21. PubMed ID: 25542899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
    Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
    J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.